Acelrx Pharmaceuticals reported $-35989000 in Equity Capital and Reserves for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acelrx Pharmaceuticals ACRX:US $ -35.99M 8.68M
Acura Pharmaceuticals ACUR:US 382K 6.52M
Baxter International BAX:US $ 8494M 42M
Becton, Dickinson and BDX:US $ 24135M 691M
Biodelivery Sciences International BDSI:US $ 113.92M 5.06M
Cara Therapeutics CARA:US $ 203.47M 26.99M
Heron Therapeutics HRTX:US $ 160.11M 36.11M
Intra Cellular Therapies ITCI:US $ 553.59M 58.56M
Pain Therapeutics PTIE:US $ 276.48M 4.71M
Smiths SMIN:LN 2.23B 143M
Teva Pharmaceutical TEVA:IT 10.32B 324M
Xeris Pharmaceuticals Inc XERS:US $ 19.89M 24.5M
Zogenix ZGNX:US $ 272.86M 48.42M